Eminence Capital’s Allergan plc AGN Stock Holding History

Eminence Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-102,071	Closed	-$27.7M	–	64
2015 Q3	$27.7M	Buy	+102,071	New	+$31.4M	0.43%	53

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Eminence Capital's AGN Position: Q4 2015 in Review

Eminence Capital sold out of Allergan plc (AGN) in Q4 2015, closing a stake of 102,071 shares — an estimated $27.7M sold.

Eminence Capital first reported a position in AGN in Q3 2015 and held it in 1 quarter. The position peaked at $27.7M in Q3 2015. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

Eminence Capital reported no remaining Allergan plc position as of Q4 2015 after selling out during the quarter.
Eminence Capital sold 102,071 Allergan plc shares in Q4 2015, an estimated $27.7M.
Eminence Capital first reported a position in Allergan plc in Q3 2015 and held it in 1 quarter.
Eminence Capital's Allergan plc position peaked at $27.7M in Q3 2015.
1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Eminence Capital's 13F filing for Q4 2015, filed 16 Feb 2016.